Get started
Author

Maria Concetta Cursano

Prognostic and predictive factors in pancreatic cancer
2020 · Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, et al. · Oncotarget · 101
PDF
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors
2019 · Chiara Casadei, Nazli Dizman, et al. · Therapeutic Advances in Medical Oncology · 98
CAR-T cell therapy: a potential new strategy against prostate cancer
2019 · Giuseppe Schepisi, Maria Concetta Cursano, et al. · Journal for ImmunoTherapy of Cancer · 97
PDF
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2024 · Brigida Anna Maiorano, Massimo Di Maio, et al. · JAMA Network Open · 61
Severe Complications in Testicular Germ Cell Tumors: The Choriocarcinoma Syndrome
2019 · Katarina Rejlekova, Maria C. Cursano, et al. · Frontiers in Endocrinology · 53
PDF
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors
2023 · Giuseppe Schepisi, Caterina Gianni, et al. · Frontiers in Immunology · 29
PDF
Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review
2020 · M.C. Cursano, M. Iuliani, et al. · Critical Reviews in Oncology/Hematology · 28
Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support
2019 · Silvia De Padova, Chiara Casadei, et al. · Frontiers in Endocrinology · 23
PDF
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study
2017 · M.E. Cazzaniga, M. Airoldi, et al. · The Breast · 22
Bone metastases from urothelial carcinoma. The dark side of the moon
2021 · Marco Stellato, Daniele Santini, et al. · Journal of bone oncology · 21
PDF
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
2020 · Giuseppe Schepisi, Vincenza Conteduca, et al. · Frontiers in Oncology · 20
PDF
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy
2020 · Maria Concetta Cursano, Barbara Kopf, et al. · Frontiers in Oncology · 19
PDF
Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study
2024 · Alberto Farolfi, Nicola Gentili, et al. · iScience · 11
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors
2019 · Giuseppe Schepisi, Nicole Brighi, et al. · Journal of Oncology · 9
PDF
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer
2025 · Vincenza Conteduca, Emanuela Scarpi, et al. · The Oncologist · 8
PDF
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies
2024 · M.C. Cursano, A.A. Valsecchi, et al. · ESMO Open · 8
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer
2022 · Sara Bleve, Maria Concetta Cursano, et al. · Frontiers in Oncology · 8
PDF
Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy
2020 · Vincenza Conteduca, Orazio Caffo, et al. · Journal of Clinical Medicine · 8
PDF
Early use of abiraterone and radium-223 in metastatic prostate cancer
2019 · Maria Concetta Cursano, Daniele Santini, et al. · The Lancet Oncology · 8
PDF
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients
2023 · Alberto Farolfi, Elisabetta Petracci, et al. · Frontiers in Oncology · 6
Response to cabozantinib in renal cell carcinoma with cardiac metastases
2020 · Marco Stellato, Maria Concetta Cursano, et al. · Anti-Cancer Drugs · 6
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study
2024 · Chiara Casadei, Emanuela Scarpi, et al. · European Urology Open Science · 5
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
2024 · Emilio Francesco Giunta, Paola Caroli, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 4
Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial
2023 · N. Brighi, V. Conteduca, et al. · ESMO Open · 4
PDF
Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer
2022 · M. C. Cursano, V. Conteduca, et al. · Scientific Reports · 4
PDF
Works count: 62
Citation count: 689
H-index: 12
I10-index: 13
Year
Topic
Type